Target intelligence / Profile preview

MT-CO2 pseudogene 23 (MTCO2P23)

Target
MTCO2P23
Molecular classification
Pseudogene, Other (non-coding, non-functional sequence resembling MT-CO2 gene), No known membership in classical protein families like receptors, enzymes, or channels
01

Overview

MT-CO2 pseudogene 23 (MTCO2P23) is a human pseudogene annotated in the genome as a non-protein-coding DNA sequence that closely resembles the functional mitochondrial MT-CO2 gene. Unlike the protein-coding MT-CO2 gene, which encodes subunit II of cytochrome c oxidase of the mitochondrial respiratory chain, MTCO2P23 does not produce a protein product and lacks biological activity. Pseudogenes can arise from duplication or retrotransposition events and may contain remnants of exonic or intronic sequences, but typically do not participate in cellular functions. There is no evidence that MTCO2P23 is translated or involved in any disease-related processes[2][4][5][7].\n\nIf the intent was to identify a disease-associated or drug-targetable gene or protein, MTCO2P23 is not correct, as it is neither a receptor, nor an enzyme, nor involved in any known cellular pathway. This entry should not be included in lists of therapeutic targets or functional biomolecules.

Other names
MT-CO2 Pseudogene 23MTCO2P23
02

Mechanism of action

None — No drugs are known to target this pseudogene.

03

Biological functions

No known biological function — pseudogenes are usually nonfunctional DNA sequences. There is no evidence that MTCO2P23 has any regulatory, signaling, or protein-coding role.
04

Disease associations

None — There are no reported disease roles, associations, or clinical relevance for MTCO2P23.
05

Safety considerations

None — Since it is not targeted or functional, there are no safety concerns or therapeutic challenges associated with MTCO2P23.
06

Interacting drugs

None — There are no known drugs that interact with MTCO2P23; pseudogenes are generally not druggable targets.
07

Biomarkers

None — MTCO2P23 is not a documented biomarker for patient selection or therapeutic monitoring.

Beyond the preview

Go deeper on MT-CO2 pseudogene 23 (MTCO2P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-CO2 pseudogene 23 (MTCO2P23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call